Platform
Features
0 followers
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Industries
Headquarters
Stage
Employees
Links
Scott Clarke
15 members
8 members
4 members
Inceptive
5 followers
Neogene Therapeutics
2 followers
Generate Biomedicines
3 followers
UpGuard
Caribou Biosciences
1 follower
Discover companies